BrightSpec

BrightSpec is commercializing its proprietary MRR lab instruments with powerful molecular ID and quant capabilities that hold significant market potential.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Charlottesville, VA, USA
  • Currency USD
  • Founded December 2012
  • Employees 14
  • Incorporation Type C-corp
  • Website brightspec.com

Company Summary

Life Science Tools: attractive market driven by innovation. BrightSpec’s MRR instruments dramatically simplify existing methods in the analytical chemistry lab. Company is in early commercial stage with some large Pharma, Chemical, and Consumer reference customers who are validating market opportunities. Equity raise to fund execution on near-term sales opportunities while funding well-defined development plan which will expand opportunity.

Team

  • Walter Colsman
    CEO

    Veteran life science equity analyst with ample startup experience, a BS in engineering from Dartmouth, and a Harvard MBA.

  • Justin Neill, Ph.D
    Chief Technology Officer

    Received his Ph.D. from UVA Pate Lab and co-invented BrightSpec’s instruments. One of most widely published researchers in the field.

  • David McDaniel
    Chief Information Officer

    Extensive experience in algorithm development and information architecture

  • Christopher Thompson
    Director, Business Development

    PhD Chemistry from Amherst. 17 year veteran of Bruker, experienced in sales, marketing, product management.

Advisors

  • Brooks Pate, Ph.D
    Unconfirmed
    Dan Armstrong, Ph.D
    Unconfirmed
    Frank Gupton, Ph.D
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free